We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BEI:XETRBeiersdorf AG Analysis

Data as of 2026-03-13 - not real-time

CN¥57.78

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Beijing Topnew is trading at CNY 57.78, just below its 20‑day SMA of 58.02 but comfortably above the 50‑day (53.88) and 200‑day (48.07) averages. The MACD histogram is positive and the signal line is bullish, while volume has been trending upward, suggesting short‑term buying pressure. However, the RSI sits at 50.7, indicating no clear momentum excess. The stock’s price is still far above the computed DCF fair value of roughly CNY 2.6, implying severe overvaluation. Revenue has contracted by 2.7% and the company posts a gross margin of –4.1% and an operating margin of –49.7%, reflecting deep profitability challenges. Negative EPS (‑0.86) and a price‑to‑book multiple of over 10× further underscore the disconnect between market price and fundamentals.
The balance sheet shows ample cash (CNY 118 M) versus modest debt, but the debt‑to‑equity ratio of 2.25 signals leverage concerns. Volatility over the past 30 days exceeds 84%, while beta is low (≈0.37), meaning the stock can swing sharply with limited market correlation. Regulatory risk in the Chinese technology sector is medium‑to‑high, and geographic concentration adds medium‑level currency risk for European investors. Liquidity appears adequate, with average daily volumes above 8 million shares and a market cap of roughly CNY 8.1 B. In sum, bullish technical signals are outweighed by weak fundamentals, high volatility, and sector‑specific risks, suggesting a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and rising volume
  • Price above key moving averages
  • Fundamental losses and extreme overvaluation

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Negative margins and earnings
  • DCF value far below market price
  • High volatility

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Sustained operating losses
  • Regulatory headwinds in Chinese tech
  • Lack of dividend and cash flow concerns

Key Metrics & Analysis

Financial Health

Revenue Growth-2.70%
Profit Margin-45.87%
ROE-15.01%
ROA-5.63%
Debt/Equity2.25
P/B Ratio10.4
Op. Cash FlowCN¥2.9M
Free Cash FlowCN¥19.7M
Industry P/E33.7

Technical Analysis

TrendBullish
RSI50.7
SupportCN¥48.18
ResistanceCN¥66.72
MA 20CN¥58.02
MA 50CN¥53.88
MA 200CN¥48.07
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥2.62
GradeOvervalued
TypeValue

Risk Assessment

Beta0.37
Volatility84.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.